Abstract:Objectives: Budget impact analysis of teriflunomide inclusion as first-line disease modifying therapy (DMT) for patients with relapsing-remitting multiple sclerosis in Russia. MethOds: Analysis was conducted with the time horizon of 5 years. Scenarios, that were considered: existing, in which teriflunomide isn't financed and patients receive interferon beta-1a (i.m. or s.c. injection), interferon beta-1b, glatiramer acetate and natalizumab, and new scenario, in which teriflunomide is financed by government. To… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.